What does the evidence say about Date Sleep Quality Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Date Sleep Quality Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Background Insomnia during pregnancy is a modifiable risk factor for depression. [Felder JN (2026); evidence level 2] - Research in nonpregnant populations and preliminary findings in a pregnant population suggest that targeting insomnia with digital cognitive behavioral therapy for insomnia (CBT-I) may prevent depression. [Felder JN (2026); evidence level 2] - 4 5 6 7 8 8 9 In recent years, evidence-based guidelines have been developed to provide clinicians and patients with structured recommendations for managing the expanding spectrum of FMS treatment options []. [Demir Ceren (2026); evidence level 2] - However, duloxetine treatment may be associated with adverse effects such as nausea, anxiety, insomnia, and diarrhea, which may negatively influence treatment adherence and overall patient well-being [,]. [Demir Ceren (2026); evidence level 2] - 4 6 10 11 12 13 14 Current guidelines consistently recommend a multimodal approach combining pharmacological and non-pharmacological strategies in the management of FMS [,,]. [Demir Ceren (2026); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.